Generic placeholder image

Current Women`s Health Reviews

Editor-in-Chief

ISSN (Print): 1573-4048
ISSN (Online): 1875-6581

Meta-Analysis

The Association Between Overweight or Obesity and the Risk of Uterine Leiomyoma: A Meta-Analysis

Author(s): Ensiyeh Jenabi, Salman Khazaei, Soodabeh Aghababaei* and Farzaneh Soltani

Volume 18, Issue 4, 2022

Published on: 17 December, 2021

Article ID: e031121195562 Pages: 6

DOI: 10.2174/1573404817666210811143213

Price: $65

Abstract

Aim: The present study is a meta-analysis to identify the relationship between BMI and uterine leiomyoma.

Methods: The major international databases PubMed, Scopus, and Web of Sciences (WOS) were searched to identify eligible studies in English language from their inception to 30 of June 2019. The pooled Odds Ratios (OR), Relative Ratio (RR), and 95% Confidence Intervals (CI) were calculated as random effect estimates of association among studies. The findings of 10 studies showed an increased risk of uterine leiomyoma in the overweight and obese women compared to women with normal weight: RR=1.21 (95% CI: 1.12, 1.30) and OR=1.50 (95% CI: 1.29, 1.71) for overweight women and RR=1.34 (95% CI: 1.11, 1.57) and OR=1.99 (95% CI: 1.11, 2.87) for obese women.

Results: Our meta-analysis suggests that obesity and overweight in women are associated with an increase in the risk of uterine leiomyoma.

Conclusion: Therefore, increased clinical attention to uterine leiomyoma should be given , because leiomyoma can be a source of mortality in women.

Keywords: Body mass index, uterine leiomyoma, Meta-analysis, obese women, uterine fibroid, muscle cell tumor.

Graphical Abstract

[1]
Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990; 94(4): 435-8.
[http://dx.doi.org/10.1093/ajcp/94.4.435] [PMID: 2220671]
[2]
Ishikawa H, Xu L, Sone K, Kobayashi T, Wang G, Shozu M. Hypoxia induces hypoxia-inducible factor 1α and potential HIF-responsive gene expression in uterine leiomyoma. Reprod Sci 2019; 26(3): 428-35.
[http://dx.doi.org/10.1177/1933719118776793] [PMID: 29779471]
[3]
Gurusamy KS, Vaughan J, Fraser IS, Best LM, Richards T. Medical therapies for uterine fibroids–a systematic review and network meta-analysis of randomised controlled trials. PLoS One 2016; 11(2): e0149631.
[http://dx.doi.org/10.1371/journal.pone.0149631] [PMID: 26919185]
[4]
Styer AK, Rueda BR. The epidemiology and genetics of uterine leiomyoma. Best Pract Res Clin Obstet Gynaecol 2016; 34: 3-12.
[http://dx.doi.org/10.1016/j.bpobgyn.2015.11.018] [PMID: 26725703]
[5]
Jenabi E, Khazaei S. The effect of uterine leiomyoma on the risk of malpresentation and cesarean: a meta-analysis. J Matern Fetal Neonatal Med 2018; 31(1): 87-92.
[http://dx.doi.org/10.1080/14767058.2016.1275553] [PMID: 28027686]
[6]
Jenabi E, Ebrahimzadeh Zagami S. The association between uterine leiomyoma and placenta abruption: A meta-analysis. J Matern Fetal Neonatal Med 2017; 30(22): 2742-6.
[http://dx.doi.org/10.1080/14767058.2016.1261401] [PMID: 27844480]
[7]
Wise LA, Laughlin-Tommaso SK. Epidemiology of uterine fibroids–from menarche to menopause. Clin Obstet Gynecol 2016; 59(1): 2-24.
[http://dx.doi.org/10.1097/GRF.0000000000000164] [PMID: 26744813]
[8]
Yang Y, He Y, Zeng Q, Li S. Association of body size and body fat distribution with uterine fibroids among Chinese women. J Womens Health (Larchmt) 2014; 23(7): 619-26.
[http://dx.doi.org/10.1089/jwh.2013.4690] [PMID: 25010826]
[9]
Okoronkwo MO. Body weight and uterine leiomyomas among women in Nigeria. West Afr J Med 1999; 18(1): 52-4.
[PMID: 10876733]
[10]
Martin CL, Huber LRB, Thompson ME, Racine EF. Serum micronutrient concentrations and risk of uterine fibroids. J Womens Health (Larchmt) 2011; 20(6): 915-22.
[http://dx.doi.org/10.1089/jwh.2009.1782] [PMID: 21671776]
[11]
Sarkodie BD, Botwe BO, Adjei DN, Ofori E. Factors associated with uterine fibroid in Ghanaian women undergoing pelvic scans with suspected uterine fibroid. Fertil Res Pract 2016; 2(1): 9.
[http://dx.doi.org/10.1186/s40738-016-0022-9] [PMID: 28620536]
[12]
Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study. Br J Obstet Gynaecol 1996; 103(9): 909-14.
[http://dx.doi.org/10.1111/j.1471-0528.1996.tb09911.x] [PMID: 8813312]
[13]
Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2009.
[14]
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629-34.
[http://dx.doi.org/10.1136/bmj.315.7109.629] [PMID: 9310563]
[15]
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414): 557-60.
[http://dx.doi.org/10.1136/bmj.327.7414.557] [PMID: 12958120]
[16]
Wise LA, Palmer JR, Spiegelman D, et al. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology 2005; 16(3): 346-54.
[http://dx.doi.org/10.1097/01.ede.0000158742.11877.99] [PMID: 15824551]
[17]
Terry KL, De Vivo I, Hankinson SE, Spiegelman D, Wise LA, Missmer SA. Anthropometric characteristics and risk of uterine leiomyoma. Epidemiology 2007; 18(6): 758-63.
[http://dx.doi.org/10.1097/EDE.0b013e3181567eed] [PMID: 17917603]
[18]
Sommer EM, Balkwill A, Reeves G, Green J, Beral DV, Coffey K. Effects of obesity and hormone therapy on surgically-confirmed fibroids in postmenopausal women. Eur J Epidemiol 2015; 30(6): 493-9.
[http://dx.doi.org/10.1007/s10654-015-0016-7] [PMID: 25784364]
[19]
Brett K. The association between body mass index, parity and history of physician diagnosed uterine leiomyomata in women 20-44 years of age. Ann Epidemiol 2008; 18(9): 737.
[http://dx.doi.org/10.1016/j.annepidem.2008.08.088]
[20]
Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. Association of physical activity with development of uterine leiomyoma. Am J Epidemiol 2007; 165(2): 157-63.
[http://dx.doi.org/10.1093/aje/kwj363] [PMID: 17090618]
[21]
Takeda T, Sakata M, Isobe A, et al. Relationship between metabolic syndrome and uterine leiomyomas: a case-control study. Gynecol Obstet Invest 2008; 66(1): 14-7.
[http://dx.doi.org/10.1159/000114250] [PMID: 18230910]
[22]
Opare-addo HS, Owiredu WK, Dapilah T. Anthropometric measures and the risk of developing leiomyoma in Ghana. 2012. Available from:. http://www.webmedcentral.com/article_view/3752
[23]
Ciavattini A, Delli Carpini G, Moriconi L, et al. The association between ultrasound-estimated visceral fat deposition and uterine fibroids: an observational study. Gynecol Endocrinol 2017; 33(8): 634-7.
[http://dx.doi.org/10.1080/09513590.2017.1302418] [PMID: 28332865]
[24]
Cook JD, Walker CL. Treatment strategies for uterine leiomyoma: the role of hormonal modulation.Seminars in reproductive medicine: 2004. 333 Seventh Avenue, New: Thieme Medical Publishers, Inc. 2004; pp. 105-11. Copyright© 2004
[25]
Dorgan JF, Reichman ME, Judd JT, et al. Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. Cancer Epidemiol Biomarkers Prev 1995; 4(4): 381-6.
[PMID: 7655334]
[26]
Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer SA, Wright R. A prospective study of hypertension and risk of uterine leiomyomata. Am J Epidemiol 2005; 161(7): 628-38.
[http://dx.doi.org/10.1093/aje/kwi072] [PMID: 15781952]
[27]
Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol 2001; 153(1): 11-9.
[http://dx.doi.org/10.1093/aje/153.1.11] [PMID: 11159140]
[28]
Lawlor DA, Bedford C, Taylor M, Ebrahim S. Agreement between measured and self-reported weight in older women. Results from the British Women’s Heart and Health Study. Age Ageing 2002; 31(3): 169-74.
[http://dx.doi.org/10.1093/ageing/31.3.169] [PMID: 12006304]
[29]
Taylor AW, Dal Grande E, Gill TK, et al. How valid are self-reported height and weight? A comparison between CATI self-report and clinic measurements using a large cohort study. Aust N Z J Public Health 2006; 30(3): 238-46.
[http://dx.doi.org/10.1111/j.1467-842X.2006.tb00864.x] [PMID: 16800200]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy